CAL-130 Racemate is primarily utilized in research settings, particularly in the study of G-protein-coupled receptors (GPCRs). It acts as a selective agonist for the GPR55 receptor, which is involved in various physiological processes, including pain modulation, bone development, and cancer progression. Researchers use CAL-130 Racemate to investigate the signaling pathways and biological functions associated with GPR55 activation. Its application helps in understanding the receptor's role in diseases and potentially identifying therapeutic targets for conditions like chronic pain, osteoporosis, and certain cancers.